Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia
Clinical trial NCT04418128 · UNKNOWN
Trial details
- NCT number
- NCT04418128
- Sponsor
- Gyeongsang National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-10
- Primary completion
- 2021-03-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.